View drug registration information details.
| Items | Registration information |
|---|
| ID | 2217 |
|---|
| No | 2217 |
|---|
| Brand Name | RELISPA INJECTION |
|---|
| Ingredients | DROTAVERINE HCL 40 MG/ 2ML |
|---|
| Dosage Form | SOLUTION FOR INJECTION |
|---|
| Primary Packaging | AMPOULES |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 25'S X 2 ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR SYMTOMATIC RELIEF OF SPASM IN INTESTINAL COLIC, BILIARY COLIC, URETERIC COLIC AND DYSMENORRHEA, IT IS ADVOCATED TO PREVENT PREMATURE LABOR AT TERM ANS ALSO TO AUGMENT LABOR WHILST LOWERING THE INCIDENC OF CERVICAL RUPTURE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | TRANSPARENT, GREENISH YELLOW COLOR LIQUID,FREE FROM ANY VISIBLE PARTICLES |
|---|
| Note | |
|---|
| License Owner | POUNSAB PHARMA CO.,LTD |
|---|
| Manufacturer | THE SEARLE COMPANY LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 05 I 5532/23 |
|---|
| FDD Registration Date | 15-MAY-2023 |
|---|
| Expiry Date | 14-MAY-2026 |
|---|
Back to drug list
|
